Health Care: Drugs

Impax Laboratories Inc (IPXL: NASDAQ)

$27.09 n/a | n/a%
10/22/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 511.50M 581.69M 512.92M 879.51M
Cost of Sales 276.86M 210.17M 235.80M 218.92M
Gross Operating Profit 234.65M 371.52M 277.12M 660.58M
Selling, General, and Administrative Expenses 120.29M 118.24M 68.48M 53.33M
Research & Development 68.85M 81.32M 82.70M 86.22M
Operating Income before D & A (EBITDA) 45.50M 171.96M 125.94M 521.03M
Depreciation & Amortization 35.35M 88.96M 18.82M 121.32M
Interest Income 1.30M 1.09M 1.15M 1.04M
Other Income - Net 152.45M -138.00K -2.59M -315.00K
Special Income / Charges -16.54M 0.00 -7.51M -6.38M
Total Income Before Interest Expenses (EBIT) 147.36M 83.94M 98.17M 394.05M
Interest Expense 419.00K 632.00K 157.00K 167.00K
Pre-Tax Income 146.94M 83.31M 98.01M 393.88M
Income Taxes 45.68M 27.44M 32.62M 143.52M
Minority Interest 0.00 0.00 -97.00K -60.00K
Net Income From Continuing Operations 101.26M 55.87M 65.40M 250.36M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 101.26M 55.87M 65.40M 250.36M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 101.26M 55.87M 65.50M 250.42M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
117.80M 55.87M 72.90M 256.74M
Preferred Dividends
Net Income Available To Common 101.26M 55.87M 65.40M 250.36M
Basic EPS from Continuing Ops. 1.51 0.85 1.02 4.04
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.51 0.85 1.02 4.04
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.51 0.85 1.02 4.04
Basic Normalized Net Income/Share 1.76 0.85 1.14 4.14
EPS fr Continuing Ops. 1.47 0.82 0.97 3.82
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.47 0.82 0.97 3.82
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.47 0.82 0.97 3.82
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.72 0.82 1.08 3.92
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IPXL

Latest IPXL Headlines from TheStreet

More Financial News for IPXL

Press Releases for IPXL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter